VNDA | Vanda Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31
Revenue	192.64M	254.38M	268.68M	248.17M	227.19M	193.12M	165.08M	146.02M	109.92M	50.16M	33.88M	32.73M	31.27M	35.22M	4.55M	N/A	N/A	N/A	N/A	33.98K
Cost of Revenue	14.80M	24.28M	25.63M	23.36M	24.49M	20.51M	17.85M	24.71M	23.46M	1.58M	N/A	129.00K	N/A	4.39M	2.90M	N/A	N/A	N/A	N/A	N/A
Gross Profit	177.84M	230.10M	243.05M	224.80M	202.70M	172.61M	147.24M	121.31M	86.46M	48.57M	33.88M	32.60M	31.27M	30.83M	1.65M	N/A	N/A	N/A	N/A	33.98K
Operating Expenses	191.80M	223.77M	200.89M	197.56M	179.89M	150.87M	164.14M	139.88M	126.65M	106.13M	54.28M	60.82M	41.98M	22.48M	37.60M	52.85M	80.04M	65.71M	24.29M	9.56M
Selling, General & Admin	112.88M	136.49M	124.05M	140.51M	129.74M	105.75M	123.84M	99.79M	84.53M	84.64M	24.59M	13.88M	11.49M	10.15M	23.72M	28.91M	32.80M	13.64M	7.40M	2.12M
Research & Development	76.82M	85.77M	75.36M	55.58M	48.65M	43.59M	38.55M	29.16M	29.14M	19.23M	28.19M	45.45M	29.00M	12.34M	13.87M	23.94M	47.23M	52.07M	16.89M	7.44M
Other Operating Expenses	2.09M	1.52M	1.48M	1.48M	1.50M	3.61M	1.47M	665.00K	320.00K	124.00K	145.00K	561.00K	1.50M	1.50M	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-13.95M	6.33M	42.16M	27.24M	22.81M	21.74M	-16.90M	-18.57M	-40.19M	20.06M	-20.40M	-28.23M	-10.71M	8.35M	-35.95M	-52.85M	-80.04M	-65.71M	-24.29M	-9.53M
Other Expenses / Income	20.29M	4.97M	199.00K	4.42M	6.22M	3.61M	1.47M	665.00K	320.00K	124.00K	145.00K	1.51M	461.00K	431.00K	89.10K	1.78M	5.98M	2.20M	410.00K	59.06K
Before Tax Income	6.34M	11.30M	42.36M	31.66M	29.03M	25.35M	-15.43M	-17.91M	-39.87M	20.19M	-20.25M	-27.66M	-10.25M	9.27M	-35.86M	-51.06M	-74.06M	-63.51M	-23.88M	-9.47M
Income Tax Expenses	3.83M	5.03M	9.21M	8.32M	-86.53M	138.00K	136.00K	104.00K	N/A	-77.62M	N/A	N/A	-444.00K	2.08M	N/A	1.78M	9.88K	549.00	7.65K	4.95K
Net Income	2.51M	6.28M	33.15M	23.34M	115.55M	25.21M	-15.57M	-18.01M	-39.87M	20.19M	-20.25M	-27.66M	-9.80M	7.19M	-35.86M	-51.06M	-74.07M	-63.51M	-23.88M	-9.47M
Interest Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	97.00	N/A	N/A	4.83K	N/A	N/A
Basic Shares Outstanding	57.38M	56.46M	55.55M	54.43M	53.14M	50.86M	44.48M	43.45M	42.25M	34.77M	30.35M	28.23M	28.11M	27.92M	27.02M	26.65M	26.36M	16.00M	21.91M	469.97M
Diluted Shares Outstanding	57.56M	56.98M	56.92M	55.19M	54.85M	53.05M	44.74M	43.45M	42.25M	36.69M	30.35M	28.23M	28.11M	28.53M	27.02M	26.65M	26.36M	16.00M	21.91M	469.97M
EBITDA	-10.94M	9.06M	45.01M	30.10M	25.70M	24.69M	-13.92M	-6.70M	-26.63M	-54.77M	-19.27M	-27.05M	-9.67M	10.67M	-34.52M	-50.53M	-73.49M	-62.93M	-23.43M	-9.15M
EBITDA Margin	-5.68%	3.56%	16.75%	12.13%	11.31%	12.79%	-8.43%	-4.59%	-24.23%	-109.20%	-56.89%	-82.65%	-30.93%	30.29%	-759.12%	0.00%	0.00%	0.00%	0.00%	-26,932.57%
EBIT	6.34M	11.30M	42.36M	31.66M	29.03M	25.35M	-15.43M	-17.91M	-39.87M	-57.43M	-20.25M	-27.66M	-10.25M	9.27M	-35.86M	-49.28M	-74.06M	-63.51M	-23.88M	-9.47M
EBIT Margin	3.29%	4.44%	15.77%	12.76%	12.78%	13.12%	-9.35%	-12.26%	-36.27%	-114.50%	-59.79%	-84.53%	-32.77%	26.32%	-788.50%	0.00%	0.00%	0.00%	0.00%	-27,867.38%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31